Osteoporosis, a condition marked by fragile bones and very low bone mineral density (BMD), was associated with an increased risk of Parkinson’s disease in postmenopausal women, a new large-scale study in Korea found. In fact, “individuals with osteoporosis had a 1.40-fold higher HR [hazard ratio] … than those with…
News
Ventus Therapeutics has dosed the first participant in its Phase 1 trial testing VENT-02, a novel oral therapy that features an inhibitor that reaches the brain and targets NLRP3 — a protein that’s linked to brain inflammation in Parkinson’s disease. The trial aims to assess the safety and…
Adhering to healthy plant-based dietary patterns was associated with a reduced risk of developing Parkinson’s disease, especially among older people, according to a large-scale U.K. study. A higher intake of vegetables, nuts, and tea in the regular diet is linked to the lowest Parkinson’s risk, data show. “These results…
Exposure to alpha-synuclein, a protein that accumulates in the brains of Parkinson’s disease patients, led to inflammation and damage to nerve cells in the gut of mice carrying a human gene associated with several autoimmune disorders, a new study showed. Alpha-synuclein-related autoimmunity also induced constipation — a gut-related…
Racial disparities exist in the use of deep brain stimulation among people with Parkinson’s disease, a real-world claims study concluded. Compared to the proportion represented in the Medicare database, more people who identified as white, and fewer Black and Hispanic patients, underwent deep brain stimulation (DBS) for Parkinson’s.
Medications commonly used in the treatment of Parkinson’s disease may affect the body’s ability to control its core temperature, part of the body’s so-called automatic functions, which include sweating, a review study found. Such agents — which include anticholinergic medications and cholinesterase inhibitors, dopamine replacement therapies, and dopamine…
Problems in quality control processes that support the health and function of mitochondria, crucial for cellular energy, are evident in nerve cells of people with Parkinson’s disease, a study showed. Mitochondrial recycling and protein balance were particularly impaired, which may impede energy production and lead to the early nerve…
The COVID-19 pandemic has had some negative physical and social impacts on the overall well-being of people with Parkinson’s disease, a new study highlights. Therefore, it’s important for clinicians to help patients get social support, not just address physical symptoms of the disease as pandemic-related restrictions ease, researchers wrote…
Rates of Parkinson’s disease progression and treatment response may differ among patients depending on whether the disease primarily affects the dominant or nondominant side of the body, a small study of typing skills in patients new to dopaminergic therapy suggests. “These findings suggest that the relationship between side of…
The Parkinson’s Solutions Summit, to be presented online from Nov. 14-20, will provide tips and practical actions to help Parkinson’s disease patients and caregivers better cope with the progressive neurodegenerative disorder. The free event will be presented by DrTalks, a platform that aims to empower people through…
Recent Posts
- Pondering the importance of routines for my dad, who has Parkinson’s
- Blood markers may help predict dementia risk in Parkinson’s disease
- How a sporting goods employee made my uncle feel seen
- Once-daily therapy eases early Parkinson’s symptoms in Phase 3 trial
- Doctors look beyond test scores to spot cognitive changes in Parkinson’s